Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 15, Issue 4, Pages 372-379
Publisher
Springer Nature
Online
2015-01-13
DOI
10.1038/tpj.2014.81
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene Dose Effects of GSTM1, GSTT1 and GSTP1 Polymorphisms on Outcome in Childhood Acute Lymphoblastic Leukemia
- (2013) Louise Borst et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantation
- (2012) Martine De Meyer et al. JOURNAL OF SURGICAL RESEARCH
- Genetic Polymorphisms in Metabolic and Cellular Transport Pathway of Methotrexate Impact Clinical Outcome of Methotrexate Monotherapy in Japanese Patients with Rheumatoid Arthritis
- (2011) Tomomi Kato et al. Drug Metabolism and Pharmacokinetics
- The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia
- (2011) Louise Borst et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway
- (2010) P. B. Grabar et al. ANNALS OF THE RHEUMATIC DISEASES
- The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number
- (2010) J. Gregers et al. BLOOD
- Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype
- (2010) H Gréen et al. PHARMACOGENOMICS JOURNAL
- Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
- (2009) K. Schmiegelow et al. BLOOD
- MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents
- (2009) Erica L. Woodahl et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia
- (2009) K Schmiegelow et al. LEUKEMIA
- Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
- (2009) C H Pui et al. LEUKEMIA
- Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
- (2009) A Möricke et al. LEUKEMIA
- Pharmacogenetics Influence Treatment Efficacy in Childhood Acute Lymphoblastic Leukemia
- (2008) Marie Louise Davidsen et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
- (2008) K Schmiegelow et al. LEUKEMIA
- Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia
- (2008) Ágnes F. Semsei et al. LEUKEMIA RESEARCH
- ABCB1 G1199A Polymorphism and Ovarian Cancer Response to Paclitaxel
- (2007) Henrik Gréen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started